While further investigations are needed to understand why the risk allele may differentially alter the expression of GPX3 in blood vs. brain (a phenomenon in ~ 5% of blood cis-eQTLs [64]), also pertinent to examine was the level of expression in an ALS cohort. Here, GPX3 is linked to amyotrophic lateral sclerosis.